Elekta Synergy S added to Johns Hopkins cancer treatment lineup
The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins School of Medicine in Baltimore added an Elekta Synergy S system to its Leksell Gamma Knife capability. With the addition of Elekta Synergy S this fall, John Hopkins will be able to fight cancer with both intracranial and extracranial resources for whole-body cancer treatment, according to the Stockholm-based company.
Elekta says its Synergy S integrates high-resolution beam shaping, precise target localization, organ motion control and 3D imaging into one package, taking stereotactic radiosurgery and radiotherapy to a new level.
Elekta Synergy S will be utilized for extracranial radiosurgery, particularly spine and liver applications, said Dr. Theodore L. DeWeese, a Johns Hopkins professor of radiation oncology, oncology and urology.
“The center expects to treat approximately 20 patients per day with Elekta Synergy S in the first year,” he said, “and about half of those will be stereotactic treatments.”
Elekta says its Synergy S integrates high-resolution beam shaping, precise target localization, organ motion control and 3D imaging into one package, taking stereotactic radiosurgery and radiotherapy to a new level.
Elekta Synergy S will be utilized for extracranial radiosurgery, particularly spine and liver applications, said Dr. Theodore L. DeWeese, a Johns Hopkins professor of radiation oncology, oncology and urology.
“The center expects to treat approximately 20 patients per day with Elekta Synergy S in the first year,” he said, “and about half of those will be stereotactic treatments.”